Hattori Y, Tazuma S, Yamashita G, Kajiyama G
First Department of Internal Medicine, Hiroshima University School of Medicine, Hiroshima, Japan.
J Gastroenterol Hepatol. 1999 Jul;14(7):669-74. doi: 10.1046/j.1440-1746.1999.01933.x.
In lithogenic bile, cholesterol-rich vesicles rapidly aggregate and fuse to eventually form cholesterol crystals. This process is modulated by cholesterol crystallization effector substances. In this study, we developed a method for quantitative assessment of vesicle fusion and used it to partly characterize the mechanisms of action of cholesterol crystallization effector proteins.
Cholesterol:phospholipid (1:1) liposomes were prepared and labelled with octadecyl rhodamine B chloride (R18). Fusion of these liposomes was detected by the increase of R18 fluorescence after incubation with various proteins, such as albumin, concanavalin-A bound glycoprotein, immunoglobulins, apolipoprotein A-I and apolipoprotein B (all at 100 microg/mL).
Fusion of cholesterol/phospholipid liposomes was increased by 16 and 14% in the presence of concanavalin-A bound glycoprotein and immunoglobulins, respectively, and decreased by 21 and 9% after addition of apolipoprotein A-I and apolipoprotein B, respectively. The effect of each protein on vesicle fusion was correlated with its hydrophobicity.
These results suggest that nucleation effector proteins modulate the stability of vesicles and, thus, affect cholesterol crystallization. Such modulation is based upon protein-vesicle association, which defines the physico-chemical metastability of vesicular cholesterol.
在致石性胆汁中,富含胆固醇的囊泡迅速聚集并融合,最终形成胆固醇晶体。这个过程受胆固醇结晶效应物质调节。在本研究中,我们开发了一种定量评估囊泡融合的方法,并利用它部分表征胆固醇结晶效应蛋白的作用机制。
制备胆固醇:磷脂(1:1)脂质体,并用十八烷基罗丹明B氯化物(R18)标记。将这些脂质体与各种蛋白质(如白蛋白、伴刀豆球蛋白A结合糖蛋白、免疫球蛋白、载脂蛋白A-I和载脂蛋白B,均为100μg/mL)孵育后,通过R18荧光增强检测脂质体的融合情况。
在伴刀豆球蛋白A结合糖蛋白和免疫球蛋白存在的情况下,胆固醇/磷脂脂质体的融合分别增加了16%和14%,而添加载脂蛋白A-I和载脂蛋白B后分别降低了21%和9%。每种蛋白质对囊泡融合的影响与其疏水性相关。
这些结果表明成核效应蛋白调节囊泡的稳定性,从而影响胆固醇结晶。这种调节基于蛋白质-囊泡结合,它决定了囊泡胆固醇的物理化学亚稳定性。